Inhibition of Multiple Myeloma Growth by Wogonin Involves Mitochondrial Apoptosis and G2/M Cycle Arrest
Authors:
- Ling HeLHLing He
- Hongwei WuHWHongwei Wu
- Zhiqiang SunZSZhiqiang Sun
- Jie ZhangJZJie Zhang
- 1 February 2024
- journal article
- research article
- Published by IMR Press in International Journal of Pharmacology
- Vol. 20 (2) , 166-173
Abstract
Inhibition of Multiple Myeloma Growth by Wogonin Involves Mitochondrial Apoptosis and G2/M Cycle ArrestKeywords
This publication has 13 references indexed in Scilit:
- Wogonin, as a potent anticancer compound: From chemistry to cellular interactionsExperimental Biology and Medicine, 2023
- Apoptosis Regulators Bcl-2 and Caspase-3Encyclopedia, 2022
- Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting itExploration of Targeted Anti-tumor Therapy, 2022
- Molecular mechanisms of cell death in neurological diseasesCell Death & Differentiation, 2021
- Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)International Journal of Oncology, 2019
- Understanding Apoptosis and Apoptotic Pathways Targeted Cancer TherapeuticsAdvanced Pharmaceutical Bulletin, 2019
- Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasionCell Adhesion & Migration, 2017
- BCL-2 family proteins: changing partners in the dance towards deathCell Death & Differentiation, 2017
- Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis , through regulating different signaling pathwaysChinese Journal of Natural Medicines, 2017
- Understanding the multiple biological aspects leading to myelomaHaematologica, 2014